Skip Navigation

Cardiovascular Research 2003 59(1):160-168; doi:10.1016/S0008-6363(03)00296-7
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lai, P. F.H
Right arrow Articles by Stewart, D. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, P. F.H
Right arrow Articles by Stewart, D. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Downregulation of eNOS mRNA expression by TNF{alpha}: identification and functional characterization of RNA–protein interactions in the 3'UTR

Patrick F.H Laia,b,1, Farida Mohameda,1,2, Juan-Carlos Mongea and Duncan J Stewarta,b,*

aThe Terrence Donnelly Research Laboratories, Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada
bInstitute of Medical Science, University of Toronto, Toronto, Ontario, Canada

* Corresponding author. Room 7-081, Queen Wing, The Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8. stewartd{at}smh.toronto.on.ca

Objective: We have previously shown that downregulation of endothelial nitric oxide synthase (eNOS) expression by tumour necrosis factor-{alpha} (TNF{alpha}) resulted entirely from the marked destabilization of the eNOS mRNA. As the 3'-untranslated region (3'UTR) in many eukaryotic mRNA has been well documented to bind regulatory trans-factors in the control of transcript stability, we have examined protein binding to this region of the eNOS mRNA. A high degree of homology amongst human and bovine 3'UTR also suggests that important functional features that are conserved through evolution are present within this region. Methods: RNA–protein interactions were studied in cross-linking assays, in which radiolabelled RNA encoding the human eNOS 3'UTR or selected sequences was incubated with cytoplasmic extracts of cultured human umbilical vein endothelial cells (HUVECs). Serial 5'- and 3'-truncated deletional mutations of the eNOS 3'UTR were generated to identify the specific binding sequences. eNOS mRNA expression in HUVECs was assessed by RT-PCR analysis. Results: Using radiolabelled RNA encoding the entire 418-nucleotide 3'UTR, we have identified ribonucleoprotein complexes (RNPs) of approximate molecular weights of 53, 56 and 66 kDa in the endothelial extracts. The formation of the 53- and 56-kDa RNPs was upregulated by TNF{alpha}, while the formation of the 66-kDa RNP was downregulated. Formation of the 53-kDa RNP was favoured by RNA fragments that contained sequences from the proximal and distal portions of the 3'UTR, whereas the formation of the 66-kDa RNP was favoured by RNA fragments with the AU-rich distal end. RNA fragments containing a CU-rich 158-nucleotide sequence from the medial portion of the eNOS 3'UTR (designated M158) favoured the formation of the 56-kDa RNP. Adenoviral gene transfer and overexpression of M158 RNA, as a protein-binding decoy to prevent the formation of the 56-kDa RNP on the endogenous transcripts, attenuated the TNF{alpha}-induced downregulation of eNOS mRNA in cultured endothelial cells. Conclusion: Our results demonstrate that the regulation of eNOS expression involves the specific binding of cytoplasmic proteins to highly conserved elements along the 3'UTR, and the 56-kDa RNP represents a novel regulatory trans-factor in the destabilization of eNOS transcripts.

KEYWORDS Gene expression; Endothelial factors; Nitric oxide synthase; Tumour necrosis factor {alpha}; RNA-binding factors


1 These authors contributed equally in this study.

2 Room 1149-1, Henry F. Hall Building, 1455 De Maisonneuve Blvd. West, Department of Chemistry & Biochemistry, Concordia University, Montréal, Québec, Canada H3G 1M8.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen
Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2399 - H2408.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Chen, H. Chai, X. Wang, J. Jiang, M. S. Jamaluddin, D. Liao, Y. Zhang, H. Wang, U. Bharadwaj, S. Zhang, et al.
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells
Blood, October 15, 2008; 112(8): 3205 - 3216.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Yan, B. You, S.-P. Chen, J. K. Liao, and J. Sun
Tumor Necrosis Factor-{alpha} Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-{alpha} 1
Circ. Res., September 12, 2008; 103(6): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Brovkovych, X.-P. Gao, E. Ong, S. Brovkovych, M.-L. Brennan, X. Su, S. L. Hazen, A. B. Malik, and R. A. Skidgel
Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L96 - L103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. D. Searles
Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C803 - C816.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Baudouin-Legros, A. Hinzpeter, A. Jaulmes, F. Brouillard, B. Costes, P. Fanen, and A. Edelman
Cell-specific posttranscriptional regulation of CFTR gene expression via influence of MAPK cascades on 3'UTR part of transcripts
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1240 - C1250.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. D. Buckley, G. E. Rainger, G. B. Nash, and K. Raza
Endothelial cells, fibroblasts and vasculitis
Rheumatology, July 1, 2005; 44(7): 860 - 863.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. D. Searles, L. Ide, M. E. Davis, H. Cai, and M. Weber
Actin Cytoskeleton Organization and Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase During Cell Growth
Circ. Res., September 3, 2004; 95(5): 488 - 495.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Tai, G. B. Robb, and P. A. Marsden
Endothelial Nitric Oxide Synthase: A New Paradigm for Gene Regulation in the Injured Blood Vessel
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 405 - 412.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.